These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4390383)

  • 1. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
    Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol).
    Kobayashi S; Hasegawa K; Mori M; Takagi H
    Arzneimittelforschung; 1970 Jan; 20(1):43-6. PubMed ID: 5467447
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H
    Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology of a new potent analgesic].
    Herrmann M; Steinbrecher W; Heldt W
    Arzneimittelforschung; 1970 Aug; 20(8):977-83. PubMed ID: 5536518
    [No Abstract]   [Full Text] [Related]  

  • 6. General pharmacology of the new antitussive levodropropizine.
    Melillo G; Malandrino S; Rossoni G; Caselli G; Bestetti A; Borsa M; Tonon GC; Berti F
    Arzneimittelforschung; 1988 Aug; 38(8):1144-50. PubMed ID: 3196408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some observations on the pharmacology of mitragynine.
    Macko E; Weisbach JA; Douglas B
    Arch Int Pharmacodyn Ther; 1972; 198(1):145-61. PubMed ID: 4626477
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent.
    Tersteege HM; Funcke AB; Louwerse WJ; Nauta WT
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):314-33. PubMed ID: 5926874
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of new tropine ethers with central activity.
    György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
    Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological studies on a substance with antitussive and respiration stimulating properties].
    Püschmann S; Engelhorn R
    Arzneimittelforschung; 1973 Feb; 23():Suppl 2a:296-3. PubMed ID: 4145312
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental studies with a new radiation protective agent].
    Szirmai E; Berkada B; Hajdukovic S; López-González JM
    Arzneimittelforschung; 1968 May; 18(5):625-8. PubMed ID: 4387834
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitussive activity and other related pharmacological properties of 2-allyoxy-4-chloro-N-(2-diethylaminoethyl) benzamide.
    Kasé Y; Kawasaki A; Miyata T; Tsumagari T; Yuizono T
    Jpn J Pharmacol; 1966 Dec; 16(4):342-52. PubMed ID: 5298923
    [No Abstract]   [Full Text] [Related]  

  • 14. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity.
    Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G
    Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on dl-glaucine phosphate as an antitussive.
    Kasé Y; Kawaguchi M; Takahama K; Miyata T; Hirotsu I; Hitoshi T; Okano Y
    Arzneimittelforschung; 1983; 33(7):936-46. PubMed ID: 6354197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711].
    Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Nov; 19(11):1820-6. PubMed ID: 4391788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacologic study of an antihistaminic derived from dibenzothiazepine].
    Allain P; Frossard J; Weber A; Chareton JY
    Therapie; 1969; 24(6):1011-26. PubMed ID: 4391606
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of a new antitussive agent: meprotixol (N 7020).
    Hougs W; Nielsen IM; Norn S; Nymark M
    Acta Pharmacol Toxicol (Copenh); 1966; 24(1):3-23. PubMed ID: 6012748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological and toxicological testing of new anti-inflammatory agent azapropazon=3-dimethylamine-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotriazine].
    Jahn U; Adrian RW
    Arzneimittelforschung; 1969 Jan; 19(1):36-52. PubMed ID: 5819362
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
    Lish PM; Weikel JH; Dungan KW
    J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.